Veröffentlichungen Suche Suche Autor/in Forschungsgruppe Veröffentlichungsdatum Wirkungsfaktor Suchen Sortieren nach RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Reihenfolge AufsteigendAbsteigend Beule, Dieter Dr. (1) Birchmeier-Kohler, Carmen Prof. Dr. (1) Blüthgen, Nils (1) Chen, Wei Prof. Dr. (2) Chu, Van Trung Dr. (1) Daniel, Peter Prof. Dr. (1) Dittmar, Gunnar Dr. (2) Di Virgilio, Michela Prof. Dr. (1) Graf, Robin Dr. (1) Hübner, Norbert Prof. Dr. (1) Janz, Martin Dr. (10) Kammertöns, Thomas Dr. (2) Kempa, Stefan Dr. (1) Kettenmann, Helmut Prof. Dr. (1) Kieback, Elisa Dr. (2) Kirchner, Marieluise Dr. (2) Kobelt, Dennis Dr. (1) Landthaler, Markus Prof. Dr. (2) Lebedeva, Svetlana (1) Leisegang, Matthias Dr. (5) Lewin, Gary Prof. Dr. (1) Lorenz, Felix Dr. (1) Mastrobuoni, Guido Dr. (1) Mathas, Stephan Dr. (13) Obenaus, Matthias (1) Obermayer-Wasserscheid, Benedikt Dr. (1) Rajewsky, Klaus Prof. Dr. (1) Rajewsky, Nikolaus Prof. Dr. (2) Selbach, Matthias Prof. Dr. (19) Sommer, Christian (1) Uckert, Wolfgang Prof. Dr. (12) Wanker, Erich Prof. Dr. (1) Wolf, Jana Prof. Dr. (1) Wyler, Emanuel Dr. (1) Zauber, Henrik Dr. (3) Zinzen, Robert Patrick Dr. (1) (-) Blankenstein, Thomas Prof. Dr. (5) (-) Lusatis, Simone (1) (-) Wollert-Wulf, Brigitte (3) (-) Biologie maligner Lymphome (3) Genetik und Genomik von Herz- Kreislauferkrankungen (1) Molekulare Immunologie und Gentherapie (9) (-) Molekulare Zellbiologie und Gentherapie (6) Systembiologie von Gen-regulatorischen Elementen (1) 1998 (2) 2000 (2) 2003 (4) 2004 (1) 2005 (3) (-) 2006 (3) 2007 (1) 2008 (1) 2010 (1) (-) 2011 (2) 2013 (2) 2014 (2) (-) 2015 (3) 2016 (1) 2017 (1) 2019 (1) 8 Ergebnisse: Active Filter: Blankenstein, Thomas Prof. Dr.Lusatis, SimoneWollert-Wulf, BrigitteBiologie maligner LymphomeMolekulare Zellbiologie und Gentherapie200620112015 Sortieren: Treffgenauigkeit Neueste nach älteste Älteste nach neueste 01. April 2015 in Curr Opin Immunol Targeting cancer-specific mutations by T cell receptor gene therapy T. Blankenstein M. Leisegang W. Uckert H. Schreiber 01. April 2015 in Nat Biotechnol Identification of human T-cell receptors with optimal affinity to cancer antigens using antigen-negative humanized mice M. Obenaus C. Leitão M. Leisegang X. Chen I. Gavvovidis P. van der Bruggen W. Uckert D.J. Schendel T. Blankenstein 01. Januar 2015 in Blood Essential role of IRF4 and MYC signaling for survival of anaplastic large cell lymphoma A. Weilemann M. Grau T. Erdmann O. Merkel U. Sobhiafshar I. Anagnostopoulos M. Hummel A. Siegert C. Hayford H. Madle B. Wollert-Wulf I. Fichtner B. Dörken S. Dirnhofer S. Mathas M. Janz N.C.T. Emre A. Rosenwald G. Ott P. Lenz A. Tzankov G. Lenz 28. Juli 2011 in Blood The only proposed T-cell epitope derived from the TEL-AML1 translocation is not naturally processed J. Popovic L.P. Li P.M. Kloetzel M. Leisegang W. Uckert T. Blankenstein 15. Januar 2011 in Int J Cancer Tumor rejection by local interferon gamma induction in established tumors is associated with blood vessel destruction and necrosis D. Briesemeister D. Sommermeyer C. Loddenkemper R. Loew W. Uckert T. Blankenstein T. Kammertoens 01. November 2006 in Eur J Immunol Designer T cells by T cell receptor replacement D. Sommermeyer J. Neudorfer M. Weinhold M. Leisegang B. Engels E. Noessner M.H. Heemskerk J. Charo D.J. Schendel T. Blankenstein H. Bernhard W. Uckert 15. März 2006 in Blood Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3) which promotes viability of Hodgkin/Reed-Sternberg cells M. Janz M. Hummel M. Truss B. Wollert-Wulf S. Mathas K. Joehrens C. Hagemeier K. Bommert H. Stein B. Doerken R.C. Bargou 01. Februar 2006 in Nat Immunol Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma S. Mathas M. Janz F. Hummel M. Hummel B. Wollert-Wulf S. Lusatis I. Anagnostopoulos A. Lietz M. Sigvardsson F. Jundt K. Joehrens K. Bommert H. Stein B. Doerken
01. April 2015 in Curr Opin Immunol Targeting cancer-specific mutations by T cell receptor gene therapy T. Blankenstein M. Leisegang W. Uckert H. Schreiber
01. April 2015 in Nat Biotechnol Identification of human T-cell receptors with optimal affinity to cancer antigens using antigen-negative humanized mice M. Obenaus C. Leitão M. Leisegang X. Chen I. Gavvovidis P. van der Bruggen W. Uckert D.J. Schendel T. Blankenstein
01. Januar 2015 in Blood Essential role of IRF4 and MYC signaling for survival of anaplastic large cell lymphoma A. Weilemann M. Grau T. Erdmann O. Merkel U. Sobhiafshar I. Anagnostopoulos M. Hummel A. Siegert C. Hayford H. Madle B. Wollert-Wulf I. Fichtner B. Dörken S. Dirnhofer S. Mathas M. Janz N.C.T. Emre A. Rosenwald G. Ott P. Lenz A. Tzankov G. Lenz
28. Juli 2011 in Blood The only proposed T-cell epitope derived from the TEL-AML1 translocation is not naturally processed J. Popovic L.P. Li P.M. Kloetzel M. Leisegang W. Uckert T. Blankenstein
15. Januar 2011 in Int J Cancer Tumor rejection by local interferon gamma induction in established tumors is associated with blood vessel destruction and necrosis D. Briesemeister D. Sommermeyer C. Loddenkemper R. Loew W. Uckert T. Blankenstein T. Kammertoens
01. November 2006 in Eur J Immunol Designer T cells by T cell receptor replacement D. Sommermeyer J. Neudorfer M. Weinhold M. Leisegang B. Engels E. Noessner M.H. Heemskerk J. Charo D.J. Schendel T. Blankenstein H. Bernhard W. Uckert
15. März 2006 in Blood Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3) which promotes viability of Hodgkin/Reed-Sternberg cells M. Janz M. Hummel M. Truss B. Wollert-Wulf S. Mathas K. Joehrens C. Hagemeier K. Bommert H. Stein B. Doerken R.C. Bargou
01. Februar 2006 in Nat Immunol Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma S. Mathas M. Janz F. Hummel M. Hummel B. Wollert-Wulf S. Lusatis I. Anagnostopoulos A. Lietz M. Sigvardsson F. Jundt K. Joehrens K. Bommert H. Stein B. Doerken
